Diagnostic information services provider Quest Diagnostics has rolled out its new lab-developed genetic test to support the delivery of modified opioid pain-relieving treatment. It effectively tests for variants in all cytochrome P450 ...
GeneInsight and Ingenuity Systems, a biomedical information and genomics analysis provider, will join forces for an integrated workflow solution, covering the annotation, analysis, assessment and reporting of human variants from ...
Tags: biomedical information, genomics analysis, clinical laboratory market
A new study has looked at how certain gene variants may predict whether an individual is likely to develop age-related macular degeneration (AMD). This eye disease affects over nine million Americans, but it has been found that certain ...
Transgenomic has entered into a collaboration agreement to provide its next-generation genetic testing services to Medical College of Wisconsin (MCW). Under the agreement, Transgenomic will provide its Nuclear Mitome test, designed to ...
Tags: genetic testing service, clinica trial, clinical technology
Medcan Clinic, a private health care clinic in Canada, has entered into a collaboration agreement with Pathway Genomics. Under the agreement, Pathway Genomics will allow Medcan's patients to use its Personal Genome Test. Using only a ...
Tags: Medcan Clinic, Pathway Genomics, collaboration agreement
How quickly your skin will age? A British firm is ready to answer this question by launching the reportedly first in-store DNA tests. These tests will allow London shoppers to choose the cream and serum genetically suited to their skin ...
Tags: skin will age, test results, genetic signatures in the DNA
San Diego-based genetic testing laboratory, Pathway Genomics, has collaborated with Diagnosticos da America (DASA). Under the partnership, DASA's physicians will have access to Pathway's Cardiac Health Insight and Pathway Fit genetic ...
Tags: DASA's physicians, Pathway Genomics, genetic testing laboratory
The cancer genetic testing services provider, NeoGenomics has launched the first molecular assay, NeoType CLL for clinical use in the US, which detects mutations in the SF3B1 gene (splicing factor 3b, subunit 1). The assay will offer ...
Tags: molecular assay, clinical research, clinical development
Akonni Biosystems has won $280,784 grant from the US National Institutes of Health (NIH) to develop a fully automated nucleic acid isolation instrument. With the grant, the company will initially use the sample preparation workstation to ...